miR-23b and miR-27b are oncogenic microRNAs in breast cancer: evidence from a CRISPR/Cas9 deletion study.

MLA

Hannafon, Bethany N., et al. “MiR-23b and MiR-27b Are Oncogenic MicroRNAs in Breast Cancer: Evidence from a CRISPR/Cas9 Deletion Study.” BMC Cancer, vol. 19, no. 1, June 2019, p. 642. EBSCOhost, https://doi.org/10.1186/s12885-019-5839-2.

APA

Hannafon, B. N., Cai, A., Calloway, C. L., Xu, Y.-F., Zhang, R., Fung, K.-M., & Ding, W.-Q. (2019). miR-23b and miR-27b are oncogenic microRNAs in breast cancer: evidence from a CRISPR/Cas9 deletion study. BMC Cancer, 19(1), 642. https://doi.org/10.1186/s12885-019-5839-2

Chicago

Hannafon, Bethany N, Angela Cai, Cameron L Calloway, Yi-Fan Xu, Roy Zhang, Kar-Ming Fung, and Wei-Qun Ding. 2019. “MiR-23b and MiR-27b Are Oncogenic MicroRNAs in Breast Cancer: Evidence from a CRISPR/Cas9 Deletion Study.” BMC Cancer 19 (1): 642. doi:10.1186/s12885-019-5839-2.